Cargando…
Impact of Chronic Kidney Disease on the Associations of Cardiovascular Biomarkers With Adverse Outcomes in Patients With Suspected or Known Coronary Artery Disease: The EXCEED‐J Study
BACKGROUND: The impact of chronic kidney disease (CKD) on the prognostic utility of cardiovascular biomarkers in high‐risk patients remains unclear. METHODS AND RESULTS: We performed a multicenter, prospective cohort study of 3255 patients with suspected or known coronary artery disease (CAD) to inv...
Autores principales: | Wada, Hiromichi, Shinozaki, Tsuyoshi, Suzuki, Masahiro, Sakagami, Satoru, Ajiro, Yoichi, Funada, Junichi, Matsuda, Morihiro, Shimizu, Masatoshi, Takenaka, Takashi, Morita, Yukiko, Yonezawa, Kazuya, Matsubara, Hiromi, Ono, Yujiro, Nakamura, Toshihiro, Fujimoto, Kazuteru, Ninomiya, Akiyo, Kato, Toru, Unoki, Takashi, Takagi, Daisuke, Wada, Kyohma, Wada, Miyaka, Iguchi, Moritake, Yamakage, Hajime, Kusakabe, Toru, Yasoda, Akihiro, Shimatsu, Akira, Kotani, Kazuhiko, Satoh‐Asahara, Noriko, Abe, Mitsuru, Akao, Masaharu, Hasegawa, Koji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238479/ https://www.ncbi.nlm.nih.gov/pubmed/35048713 http://dx.doi.org/10.1161/JAHA.121.023464 |
Ejemplares similares
-
Distinct Characteristics of VEGF‐D and VEGF‐C to Predict Mortality in Patients With Suspected or Known Coronary Artery Disease
por: Wada, Hiromichi, et al.
Publicado: (2020) -
Impact of Smoking Status on Growth Differentiation Factor 15 and Mortality in Patients With Suspected or Known Coronary Artery Disease: The ANOX Study
por: Wada, Hiromichi, et al.
Publicado: (2020) -
VEGF‐C and Mortality in Patients With Suspected or Known Coronary Artery Disease
por: Wada, Hiromichi, et al.
Publicado: (2018) -
Soluble vascular endothelial growth factor receptor 2 and prognosis in patients with chronic heart failure
por: Iguchi, Moritake, et al.
Publicado: (2021) -
Effects of high-absorption curcumin for the prevention of hypertensive heart disease: a double-blind, placebo-controlled, randomized clinical study
por: Funamoto, Masafumi, et al.
Publicado: (2022)